5,6-dihydro-5-azacytidine April 12, 2017 5,6-dihydro-5-azacytidine Trade Name Orphan Indication Malignant mesothelioma USA Market Approval USA USA Designation Date 1992-05-11 00:00:00 Sponsor ILEX Oncology, Inc.;4545 Horizon Hill Blvd.;San Antonio, Texas, 78229
